Click for best price
Prostate Cancer Diagnostics Treatment Market Size, Share 2023
Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.
This report contains market size and forecasts of Prostate Cancer Diagnostics and Treatment in Global, including the following market information:
Global Prostate Cancer Diagnostics and Treatment Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Prostate Cancer Diagnostics and Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Biological Therapy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Diagnostics and Treatment include Tolmar, Astellas Pharma, AstraZeneca, Ferring Pharmaceuticals, Johnson & Johnson, Abbott, Sanofi, Ipsen and Novartis, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Diagnostics and Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Diagnostics and Treatment Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Prostate Cancer Diagnostics and Treatment Market Segment Percentages, by Type, 2022 (%)
Biological Therapy
Chemotherapy
Global Prostate Cancer Diagnostics and Treatment Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Prostate Cancer Diagnostics and Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital
Research Institution
Clinic
Global Prostate Cancer Diagnostics and Treatment Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Prostate Cancer Diagnostics and Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Diagnostics and Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prostate Cancer Diagnostics and Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Tolmar
Astellas Pharma
AstraZeneca
Ferring Pharmaceuticals
Johnson & Johnson
Abbott
Sanofi
Ipsen
Novartis
Bayer
| Report Attributes |
Report Details |
| Report Title |
Prostate Cancer Diagnostics and Treatment Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Diagnostics and Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Diagnostics and Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Diagnostics and Treatment Overall Market Size
2.1 Global Prostate Cancer Diagnostics and Treatment Market Size: 2022 VS 2030
2.2 Global Prostate Cancer Diagnostics and Treatment Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Diagnostics and Treatment Players in Global Market
3.2 Top Global Prostate Cancer Diagnostics and Treatment Companies Ranked by Revenue
3.3 Global Prostate Cancer Diagnostics and Treatment Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnostics and Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Diagnostics and Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnostics and Treatment Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Diagnostics and Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics and Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Prostate Cancer Diagnostics and Treatment Market Size Markets, 2022 & 2030
4.1.2 Biological Therapy
4.1.3 Chemotherapy
4.2 By Type - Global Prostate Cancer Diagnostics and Treatment Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Diagnostics and Treatment Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Diagnostics and Treatment Revenue, 2023-2030
4.2.3 By Type - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Diagnostics and Treatment Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Research Institution
5.1.4 Clinic
5.2 By Application - Global Prostate Cancer Diagnostics and Treatment Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Diagnostics and Treatment Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Diagnostics and Treatment Revenue, 2023-2030
5.2.3 By Application - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Prostate Cancer Diagnostics and Treatment Market Size, 2022 & 2030
6.2 By Region - Global Prostate Cancer Diagnostics and Treatment Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Diagnostics and Treatment Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Diagnostics and Treatment Revenue, 2023-2030
6.2.3 By Region - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Prostate Cancer Diagnostics and Treatment Revenue, 2018-2030
6.3.2 US Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.3.3 Canada Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.3.4 Mexico Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Diagnostics and Treatment Revenue, 2018-2030
6.4.2 Germany Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.4.3 France Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.4.4 U.K. Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.4.5 Italy Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.4.6 Russia Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.4.7 Nordic Countries Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.4.8 Benelux Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Diagnostics and Treatment Revenue, 2018-2030
6.5.2 China Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.5.3 Japan Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.5.4 South Korea Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.5.5 Southeast Asia Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.5.6 India Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Prostate Cancer Diagnostics and Treatment Revenue, 2018-2030
6.6.2 Brazil Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.6.3 Argentina Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Diagnostics and Treatment Revenue, 2018-2030
6.7.2 Turkey Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.7.3 Israel Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.7.4 Saudi Arabia Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
6.7.5 UAE Prostate Cancer Diagnostics and Treatment Market Size, 2018-2030
7 Players Profiles
7.1 Tolmar
7.1.1 Tolmar Corporate Summary
7.1.2 Tolmar Business Overview
7.1.3 Tolmar Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.1.4 Tolmar Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.1.5 Tolmar Key News
7.2 Astellas Pharma
7.2.1 Astellas Pharma Corporate Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.2.4 Astellas Pharma Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.2.5 Astellas Pharma Key News
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.3.4 AstraZeneca Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca Key News
7.4 Ferring Pharmaceuticals
7.4.1 Ferring Pharmaceuticals Corporate Summary
7.4.2 Ferring Pharmaceuticals Business Overview
7.4.3 Ferring Pharmaceuticals Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.4.4 Ferring Pharmaceuticals Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.4.5 Ferring Pharmaceuticals Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.5.4 Johnson & Johnson Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News
7.6 Abbott
7.6.1 Abbott Corporate Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.6.4 Abbott Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.6.5 Abbott Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.7.4 Sanofi Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.7.5 Sanofi Key News
7.8 Ipsen
7.8.1 Ipsen Corporate Summary
7.8.2 Ipsen Business Overview
7.8.3 Ipsen Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.8.4 Ipsen Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.8.5 Ipsen Key News
7.9 Novartis
7.9.1 Novartis Corporate Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.9.4 Novartis Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.9.5 Novartis Key News
7.10 Bayer
7.10.1 Bayer Corporate Summary
7.10.2 Bayer Business Overview
7.10.3 Bayer Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.10.4 Bayer Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.10.5 Bayer Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Diagnostics and Treatment Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Diagnostics and Treatment Market Drivers in Global Market
Table 3. Prostate Cancer Diagnostics and Treatment Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Diagnostics and Treatment in Global Market
Table 5. Top Prostate Cancer Diagnostics and Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prostate Cancer Diagnostics and Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prostate Cancer Diagnostics and Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prostate Cancer Diagnostics and Treatment Product Type
Table 9. List of Global Tier 1 Prostate Cancer Diagnostics and Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics and Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Prostate Cancer Diagnostics and Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prostate Cancer Diagnostics and Treatment Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Prostate Cancer Diagnostics and Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prostate Cancer Diagnostics and Treatment Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2023-2030
Table 30. Tolmar Corporate Summary
Table 31. Tolmar Prostate Cancer Diagnostics and Treatment Product Offerings
Table 32. Tolmar Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn), (2018-2023)
Table 33. Astellas Pharma Corporate Summary
Table 34. Astellas Pharma Prostate Cancer Diagnostics and Treatment Product Offerings
Table 35. Astellas Pharma Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn), (2018-2023)
Table 36. AstraZeneca Corporate Summary
Table 37. AstraZeneca Prostate Cancer Diagnostics and Treatment Product Offerings
Table 38. AstraZeneca Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn), (2018-2023)
Table 39. Ferring Pharmaceuticals Corporate Summary
Table 40. Ferring Pharmaceuticals Prostate Cancer Diagnostics and Treatment Product Offerings
Table 41. Ferring Pharmaceuticals Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn), (2018-2023)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Prostate Cancer Diagnostics and Treatment Product Offerings
Table 44. Johnson & Johnson Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn), (2018-2023)
Table 45. Abbott Corporate Summary
Table 46. Abbott Prostate Cancer Diagnostics and Treatment Product Offerings
Table 47. Abbott Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn), (2018-2023)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Prostate Cancer Diagnostics and Treatment Product Offerings
Table 50. Sanofi Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn), (2018-2023)
Table 51. Ipsen Corporate Summary
Table 52. Ipsen Prostate Cancer Diagnostics and Treatment Product Offerings
Table 53. Ipsen Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn), (2018-2023)
Table 54. Novartis Corporate Summary
Table 55. Novartis Prostate Cancer Diagnostics and Treatment Product Offerings
Table 56. Novartis Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn), (2018-2023)
Table 57. Bayer Corporate Summary
Table 58. Bayer Prostate Cancer Diagnostics and Treatment Product Offerings
Table 59. Bayer Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Prostate Cancer Diagnostics and Treatment Segment by Type in 2022
Figure 2. Prostate Cancer Diagnostics and Treatment Segment by Application in 2022
Figure 3. Global Prostate Cancer Diagnostics and Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Diagnostics and Treatment Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Prostate Cancer Diagnostics and Treatment Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Diagnostics and Treatment Revenue in 2022
Figure 8. By Type - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2030
Figure 9. By Application - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2030
Figure 10. By Region - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2030
Figure 11. By Country - North America Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2030
Figure 12. US Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2030
Figure 16. Germany Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 17. France Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2030
Figure 24. China Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 28. India Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2030
Figure 30. Brazil Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2030
Figure 33. Turkey Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2030
Figure 37. Tolmar Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Astellas Pharma Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. AstraZeneca Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Ferring Pharmaceuticals Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Johnson & Johnson Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Ipsen Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bayer Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
